Reuters logo
BRIEF-Endocyte Inc presents data at AACR identifying multiple methods for managing severe side effects resulting from car t-cell treatment
2017年4月5日 / 下午1点09分 / 8 个月前

BRIEF-Endocyte Inc presents data at AACR identifying multiple methods for managing severe side effects resulting from car t-cell treatment

April 5 (Reuters) - Endocyte Inc

* Endocyte Inc - presents data at AACR identifying multiple methods for managing severe side effects resulting from car t-cell treatment

* Endocyte Inc - late-breaking poster demonstrates that Endocyte’s bi-specific adaptor molecules can mitigate or eliminate cytokine storms

* Endocyte - data presented shows how co’s bi-specific SMDC adaptors can potentially improve safety, tolerability profiles of current car t-cell therapies Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below